Tamper-evidence – A Vital Matter of Safet

Jan 8, 2016

This article, written by Alessio Bressan at IGGB and starting from the concept of falsified medicine as postulated in the European directive, focuses on the options actually on the market concerning tamper-evident systems. It closes by demonstrating how a system integrated in the outer packaging and completely mechanical is able to improve the safety of the outer packaging and protect it against counterfeit attempts in an effective way. ...

Read More

It’s Time to Address the Claims Management Disconnect

Jan 8, 2016

One of the fundamental pillars of the life sciences industry is the accuracy of the claims that it makes for its products. Over decades, the industry has strived to become second to none in terms of testing and transparency, because what it says about its products has the potential to impact ultimately upon hundreds of millions of patients and consumers. And arguably, no other industry is subject to the same level of regulatory scrutiny. James Brown, VP & GM Commercial Content at Veeva/Zinc reflects on the claims management disconnect. ...

Read More

Physicians’ Preferences on Contact Methods and Survey Administration in Asia Pacific

Jan 7, 2016

Email is the most commonly-used method to contact physicians for feasibility studies. Feasibility studies often have a short turnaround time, requiring physicians to complete the survey expeditiously. The objective of this article is to find out the preferred method of contact by the physicians as well as their acceptance of the various methods of survey administration, hence facilitating the process for short response time. Audrey Ho at Quintiles guides us into the Asia Pacific, explaining physicians’ preferences on contact methods and survey administration. ...

Read More

Life Sciences in Asia – Nick Stephens, RSA

Jun 30, 2015

Is the Tiger an Endangered Species? The story of Western expansion into the life sciences in Asia has been one of rapid change. Nick Stephens, Executive Chairman of RSA, the leading global life sciences executive search and executive interims specialist, explains how the war for talent in Asia has been adapting to the unpredictable landscape. ...

Read More